BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Ceres Inc. Obtains Commercial License From Japan Tobacco


10/19/2005 5:11:00 PM

LOS ANGELES, April 22 /PRNewswire/ -- Ceres, Inc., a leading biotechnology company developing high value plants and plant-based products to benefit human health and agriculture has obtained a commercial license from Japan Tobacco Inc. for a proprietary transformation system known as PureIntro(TM). Terms of the agreement were not disclosed.

"We are very pleased to have secured a license to PureIntro(TM) technology. This is an important tool for commercializing high-value plants and plant-based products," stated Richard Flavell, the Chief Scientific Officer of Ceres. He added, "Ceres has identified the biological roles of thousands of genes related to crop traits using its large collection of full-length cDNAs. Ceres is now moving rapidly to designing breakthrough traits. Having access to the PureIntro(TM) transformation technology will speed up our product development efforts in many economically valuable crops."

About Ceres, Inc.

Ceres, Inc. is a privately held biotechnology company utilizing multiple integrated plant genomics technologies to develop innovative products. In addition to pursuing opportunities in the food, feed and fiber industries, Ceres' business strategy consists of leveraging its technology platform in the agrochemical, chemical and pharmaceutical industries. For more information visit our web site at http://www.ceresbiotechnology.com/

About Japan Tobacco Inc.

Japan Tobacco Inc. is the world's third largest international manufacturer of tobacco products. The company manufactures internationally recognized cigarette brands including Camel, Winston, Mild Seven and Salem. Since its privatization in 1985, JT has actively diversified its operations into pharmaceuticals and foods. The company net sales were JPY 4.492 trillion in the fiscal year ended March 31, 2003.

Ceres, Inc.

CONTACT: Peter Mascia, Vice President of Business Development of Ceres,Inc., +1-310-317-8900


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->